TRAW
Traws Pharma Inc
NASDAQ · Pharmaceuticals
$1.96
+0.24 (+13.95%)
Open$1.79
Previous Close$1.72
Day High$2.01
Day Low$1.79
52W High$26.17
52W Low$17.49
Volume—
Avg Volume190.3K
Market Cap15.66M
P/E Ratio20.70
EPS$0.95
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+1,034.7% upside
Current
$1.96
$1.96
Target
$22.24
$22.24
$15.33
$22.24 avg
$34.90
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 4.81M | 4.77M | 3.83M |
| Net Income | 633.7K | 796.1K | 510.0K |
| Profit Margin | 13.2% | 16.7% | 13.3% |
| EBITDA | 1.15M | 1.15M | 1.01M |
| Free Cash Flow | 870.8K | 772.5K | 534.0K |
| Rev Growth | +22.7% | +21.0% | +9.5% |
| Debt/Equity | 0.81 | 0.64 | 0.73 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |